Tiziana Life Sciences Ltd (TLSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 88.12M |
| Enterprise Value | 84.57M |
| P/E Ratio | -4.05 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.37 |
| Return On Equity | -1.26 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -234,000 |
| EBITDA | -21.05M |
| Net Income | -18.43M |
| Diluted EPS | -0.32 |
| Total Cash | 4.01M |
| Total Cash/Share | 0.48 |
| Total Debt | 456,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.79 |
| Book Value Per Share | 0.46 |
| 52-Week Change | -25.81 |
| 52-Week High | 2.6 |
| 52-Week Low | 1.04 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 1.55 |
| Average Volume | 214,029 |
| Shares Outstanding | 63.63M |
| % Held by Institutions | 5.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | October 21, 2021 |